These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 4280473)
1. [Reactivity of lymphocytes in patients after kidney homotransplantation]. Kopelian II; Grigor'eva MP; Govallo VI; Shumakov VI Khirurgiia (Mosk); 1974 Dec; (12):85-8. PubMed ID: 4280473 [No Abstract] [Full Text] [Related]
2. Changes in human mixed lymphocyte culture reactivity as an indicator of kidney rejection. Hattler BG; Miller J Transplant Proc; 1972 Dec; 4(4):655-7. PubMed ID: 4264870 [No Abstract] [Full Text] [Related]
3. [The significance of mixed lymphocyte culture and mitogen-stimulated culture for kidney transplantation (author's transl)]. Hajek-Rosenmayr A; Wolf A Wien Klin Wochenschr; 1981 Jul; 93(14):457-60. PubMed ID: 6455859 [TBL] [Abstract][Full Text] [Related]
4. Allogeneic kidney cells stimulate the production of immunoregulatory cytokines in mixed kidney lymphocyte culture. Takahara S; Moutabarrik A; Namiki M; Yamaguchi S; Kameoka H; Ishibashi M; Zaid D; Okuyama A Transplant Proc; 1993 Jun; 25(3):2314. PubMed ID: 8516912 [No Abstract] [Full Text] [Related]
5. Pretransplant blood transfusions and kidney allograft survival. A clinical and immunological study. Fehrman I Scand J Urol Nephrol Suppl; 1981; 65():1-46. PubMed ID: 6217543 [No Abstract] [Full Text] [Related]
6. Correlation of mixed lymphocyte culture reactivity and graft survival in one haplotype-matched recipients. Garovoy MR; Person A; Carpenter CB Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():208-11. PubMed ID: 158753 [No Abstract] [Full Text] [Related]
7. Tissue typing by unidirectional mixed lymphocyte culture. 3. The relationship of in vitro lymphocyte compatibility to renal allograft rejection. Tsunemitsu K Acta Med Okayama (1952); 1971; 25(1):65-9. PubMed ID: 4258666 [No Abstract] [Full Text] [Related]
8. In vitro studies of the human response to organ allografts: appearance and detection of circulating activation lymphocytes. Hersh EM; Butler WT; Rossen RD; Morgan RO; Suki W J Immunol; 1971 Aug; 107(2):571-8. PubMed ID: 4936291 [No Abstract] [Full Text] [Related]
10. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced. van Besouw NM; van der Mast BJ; de Kuiper P; Smak Gregoor PJ; Vaessen LM; IJzermans JN; van Gelder T; Weimar W Transplantation; 2000 Jul; 70(1):136-43. PubMed ID: 10919590 [TBL] [Abstract][Full Text] [Related]
11. Use of monoclonal antibodies to study in vivo and in vitro-activated lymphocytes. Aversa GG; Waugh JA; Bishop GA; Hall BM Transplant Proc; 1989 Feb; 21(1 Pt 1):349-50. PubMed ID: 2650146 [No Abstract] [Full Text] [Related]
14. Studies on the human mixed lymphocyte culture. II. Comparison of one-way and two-way test performed on lymphocytes of patients with end-stage renal failure and their prospective living donors. Wojtulewicz-Kurkus J; Skopińska E; Nowaczyk M; Klepacka J Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1005-7. PubMed ID: 155431 [TBL] [Abstract][Full Text] [Related]
15. [Immunological diagnosis of the kidney allograft rejection reaction]. Drannik GN Urol Nefrol (Mosk); 1981; (5):64-71. PubMed ID: 6458144 [No Abstract] [Full Text] [Related]
16. [Immunological after-care in kidney transplantation]. Friemel H Zentralbl Chir; 1975; 100(20):1241-6. PubMed ID: 174341 [No Abstract] [Full Text] [Related]